Riddhi Siddhi Gluco Biols Ltd Falls to 52-Week Low of Rs.433.25

Stock Price Movement and Market Context

On 30 Dec 2025, the stock recorded an intraday high of Rs.452, up 2.42% from the previous close, but ultimately closed lower, reflecting a day’s decline of 1.37%. This marks the fifth consecutive day of losses, with the stock falling by 6.93% over this period. The current price of Rs.433.25 is substantially below its 52-week high of Rs.691, underscoring a steep downward trajectory.

Riddhi Siddhi Gluco Biols Ltd’s performance today also lagged behind its sector peers, underperforming the Trading & Distributors sector by 0.8%. The stock is trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling sustained bearish momentum.

In contrast, the Sensex index, while down by 0.12% at 84,594.05 points after opening 94.55 points lower, remains relatively resilient, trading just 1.85% below its 52-week high of 86,159.02. The Sensex’s 50-day moving average remains above its 200-day average, indicating a generally positive medium-term market trend that Riddhi Siddhi Gluco Biols Ltd has not mirrored.

Financial Performance and Fundamental Concerns

The company’s financial metrics reveal a challenging environment. Over the last five years, Riddhi Siddhi Gluco Biols Ltd has experienced a negative compound annual growth rate (CAGR) of -14.03% in net sales, reflecting a contraction in revenue generation. This weak long-term growth has contributed to the stock’s deteriorating valuation and investor sentiment.

Profitability metrics have also been under pressure. The company’s Earnings Before Interest and Taxes (EBIT) to interest ratio averages at -1.18, indicating difficulties in servicing debt obligations. This is compounded by reported losses over the last three consecutive quarters, with the Profit After Tax (PAT) for the nine-month period standing at Rs.27.63 crore, down by 61.36% year-on-year.

Quarterly net sales have declined sharply by 34.36% to Rs.32.10 crore, while Profit Before Tax excluding other income (PBT less OI) has fallen by 225%, registering a loss of Rs.4.05 crore. These figures highlight the company’s ongoing struggles to maintain revenue and profitability levels.

Valuation and Risk Profile

The stock’s current valuation is considered risky relative to its historical averages. Over the past year, the stock has generated a negative return of 32.10%, significantly underperforming the Sensex, which posted an 8.09% gain over the same period. This underperformance extends beyond the last year, with the stock lagging the BSE500 index over the last three years, one year, and three months.

Negative EBITDA figures further accentuate the risk profile, reflecting operational losses that have persisted. The company’s return on capital employed (ROCE) is negative, a direct consequence of sustained losses and weak earnings before interest and taxes.

Promoters remain the majority shareholders, maintaining control over the company’s strategic direction despite the financial headwinds.

Mojo Score and Market Sentiment

Riddhi Siddhi Gluco Biols Ltd currently holds a Mojo Score of 3.0, with a Mojo Grade of Strong Sell as of 1 Feb 2025, downgraded from a previous Sell rating. This grading reflects the company’s deteriorated fundamentals and heightened risk factors. The Market Cap Grade stands at 4, indicating a relatively modest market capitalisation within its sector.

The downgrade to Strong Sell underscores the challenges faced by the company in reversing its financial decline and improving its market standing.

Summary of Key Metrics

To summarise, the stock’s 52-week low of Rs.433.25 is a culmination of several adverse factors:

• Five consecutive days of price decline, totalling a 6.93% loss in that period


• Negative five-year CAGR in net sales of -14.03%


• Three consecutive quarters of losses with declining PAT and net sales


• Negative EBIT to interest ratio averaging -1.18, indicating debt servicing difficulties


• Negative ROCE and EBITDA, reflecting ongoing profitability challenges


• Underperformance relative to Sensex and sector indices over multiple time frames

These factors collectively contribute to the stock’s current valuation and market position.

Market and Sector Comparison

While the broader market, as represented by the Sensex, remains near its 52-week high and maintains a positive medium-term trend, Riddhi Siddhi Gluco Biols Ltd’s share price trajectory diverges sharply. The Trading & Distributors sector itself has outperformed the stock on the day, highlighting relative weakness in the company’s performance within its industry.

The stock’s position below all major moving averages further emphasises the prevailing downward momentum, contrasting with the broader market’s more stable technical indicators.

Shareholding and Control

The company’s promoter group continues to hold the majority stake, maintaining control over corporate decisions. This concentrated ownership structure remains unchanged despite the stock’s recent price movements and financial results.

Conclusion

Riddhi Siddhi Gluco Biols Ltd’s fall to a 52-week low of Rs.433.25 reflects a combination of sustained financial underperformance, negative profitability metrics, and relative weakness compared to market and sector benchmarks. The stock’s current valuation and risk profile are consistent with its downgraded Mojo Grade of Strong Sell, highlighting the challenges faced by the company in recent periods.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Today